Phantom Neuro’s Implantable Interface for Next-Generation Prosthetics

Phantom Neuro has developed a platform designed to help individuals with limb loss regain functional control of 
prosthetic devices [1]. On April 15th, Phantom Neuro received regulatory and ethics approval to begin recruitment 
for its first human Early Feasibility Study (EFS) in Australia [2]. The study will include 10 participants, each 
undergoing a single outpatient procedure, followed by a two-week recovery period and 20 weeks of evaluation. 
The device itself is a minimally invasive, implantable sensor less than 3 mm thick, capable of detecting the electrical 
activity of underlying muscles. This enables intuitive control of prosthetic limbs, including advanced hand 
movements, through a seamless interface beneath the skin.
This technology has the potential not only to revolutionize prosthetic control but also to fundamentally reshape how 
humans interact with assistive devices, bridging the gap between biological and engineered systems.

Article written by Jennifer Joanna-Joan Villeneuve,
M.ESc Biomedical Engineering Candidate, B.ESc Mechatronic Systems & B.ESc Biomedical Engineering

References
[1] “Phantom Neuro Registry.” Accessed: Apr. 15, 2026. [Online]. Available: https://registry.phantomneuro.com/
[2] P. N. Inc, “Phantom Neuro Receives Approval for First-In-Human Clinical Study.” Accessed: Apr. 15, 2026. 
[Online]. Available: https://www.prnewswire.com/news-releases/phantom-neuro-re

Back To Medical Marketing